UK fertile ground for switching

With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescriptionto- OTC reclassification. David Ridley explores the country’s increasingly attractive switch environment.

More from Archive

More from HBW Insight